PP201—An Open-Label, Randomized, Single-Centre, Four-Way Crossover Study to Evaluate the Pharmacokinetics of Single, Oral Doses of Retigabine/Ezogabine in Healthy Adult Taiwanese Subjects

Autor: Buraglio, M.
Zdroj: In Clinical Therapeutics August 2013 35(8) Supplement:e80-e80
Databáze: ScienceDirect